Education
About Us
Working with TipRanks
Follow Us
Eli Lilly And Company (LLY)
:LLY
LLY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$711.40 - $972.53
Previous CloseN/A
Volume1.27M
Average Volume (3M)3.48M
Market Cap
$863.84B
Enterprise Value$761.80B
Total Cash (Recent Filing)$3.27B
Total Debt (Recent Filing)$33.64B
Price to Earnings (P/E)77.8
Beta0.55
Next Earnings
May 01, 2025EPS Estimate
4.68Last Dividend Ex-Date
Feb 14, 2025Dividend Yield0.59%
Share Statistics
EPS (TTM)11.49
Shares Outstanding948,170,000
10 Day Avg. Volume3,555,133
30 Day Avg. Volume3,477,662
Financial Highlights & Ratios
PEG Ratio0.76
Price to Book (P/B)N/A
Price to Sales (P/S)19.18
Price to Cash Flow (P/CF)87.30
P/FCF Ratio220.90
Enterprise Value/Market Cap0.88
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit20.80
Enterprise Value/Ebitda48.75
Forecast
1Y Price Target
$1,029.14Price Target Upside10.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
---
Bulls Say, Bears Say
Bulls Say
Market Share GrowthLilly continues to outgrow Novo with market share stretching towards equal.
Product Launch And InnovationThere is increasing optimism for Orforglipron due to LLY's confidence in the asset and the potential for a bold-global launch with commercially creative options.
Bears Say
Market Penetration ChallengesZepbound vials make up a low/mid-single-digit percentage of total scripts, signaling limited market penetration.
---
Ownership Overview
10.33% Insiders
22.65% Mutual Funds
27.58% Other Institutional Investors
23.58% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LLY FAQ
What was Eli Lilly And Company’s price range in the past 12 months?
Eli Lilly And Company lowest stock price was $711.40 and its highest was $972.53 in the past 12 months.
What is Eli Lilly And Company’s market cap?
Eli Lilly And Company’s market cap is $863.84B.
When is Eli Lilly And Company’s upcoming earnings report date?
Eli Lilly And Company’s upcoming earnings report date is May 01, 2025 which is in 56 days.
How were Eli Lilly And Company’s earnings last quarter?
Eli Lilly And Company released its earnings results on Feb 06, 2025. The company reported $5.32 earnings per share for the quarter, beating the consensus estimate of $5.045 by $0.275.
Is Eli Lilly And Company overvalued?
According to Wall Street analysts Eli Lilly And Company’s price is currently Undervalued.
Does Eli Lilly And Company pay dividends?
Eli Lilly And Company pays a Quarterly dividend of $5.397 which represents an annual dividend yield of 0.59%. See more information on Eli Lilly And Company dividends here
What is Eli Lilly And Company’s EPS estimate?
Eli Lilly And Company’s EPS estimate is 4.68.
How many shares outstanding does Eli Lilly And Company have?
Eli Lilly And Company has 948,170,000 shares outstanding.
What happened to Eli Lilly And Company’s price movement after its last earnings report?
Eli Lilly And Company reported an EPS of $5.32 in its last earnings report, beating expectations of $5.045. Following the earnings report the stock price went up 3.347%.
Which hedge fund is a major shareholder of Eli Lilly And Company?
Currently, no hedge funds are holding shares in LLY
---
Eli Lilly & Co Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1,029.14 (10.69% Upside)
$1,029.14 (10.69% Upside)
Blogger Sentiment
Bullish
LLY Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 644.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.2B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.34%
12-Months-Change
Fundamentals
Return on Equity
84.84%
Trailing 12-Months
Asset Growth
22.98%
Trailing 12-Months
Company Description
Eli Lilly And Company
Eli Lilly & Co (LLY) is a global pharmaceutical company that discovers, develops, manufactures, and markets products in human health. The company focuses on several key therapeutic areas, including diabetes, oncology, immunology, neurodegeneration, and pain management. With a robust portfolio of innovative medicines, Eli Lilly aims to improve patient outcomes and address unmet medical needs worldwide.
---
LLY Company Deck
---
LLY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and successful product launches, underpinned by strategic investments and advancements in the pipeline. However, challenges such as pricing pressures, a decline in Trulicity revenue, and supply constraints in certain regions tempered the overall positive outlook.Read More>---
LLY Revenue Breakdown
67.44% U.S.
15.36% Europe
9.48% ROW
4.03% Japan
3.69% China
---
LLY Stock 12 Month Forecast
Average Price Target
$1,029.14
▲(10.69% Upside)
Technical Analysis
Best Analysts Covering LLY
1 Year
1 Year Success Rate
36/36 ratings generated profit
1 Year Average Return
+49.32%
reiterated a buy rating 10 days ago
Copying Evan Seigerman's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +49.32% per trade.
---